• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

FDA advisory panels

FDA advisory votes against BrainsGate’s neurostim device for treating stroke

December 13, 2021 By Sean Whooley

At the end of last week, an FDA advisory panel voted down BrainsGate’s neurostimulation device for treating stroke. BrainsGate designed its technology as a five-minute procedure. A neurostimulator implant is injected into an existing canal to stimulate a nerve center and augment collateral blood flow, improving stroke patients’ outcomes within a 24-hour window. The platform […]

Filed Under: Blood Management, Featured, Food & Drug Administration (FDA), Implants, Neurological, Neuromodulation/Neurostimulation, News Well, Regulatory/Compliance Tagged With: BrainsGate, FDA, FDA advisory panels

FDA advisory panel gives positive ruling on TransMedics OCS Liver System

July 15, 2021 By Sean Whooley

TransMedics (NSDQ:TMDX) announced last night that an FDA advisory panel issued a favorable vote supporting approval for its OCS Liver System. Yesterday, the Nasdaq market halted trading of TransMedics’ common stock as it awaited the outcome of a meeting of the FDA’s Gastroenterology and Urology Devices Panel of the Medical Devices Advisory Committee, set to review […]

Filed Under: Business/Financial News, Featured, Food & Drug Administration (FDA), Pre-Market Approval (PMA), Regulatory/Compliance, Transplants, Wall Street Beat Tagged With: FDA, FDA advisory panels, transmedics

Nasdaq halts trading of TransMedics stock with FDA set to review OCS Liver System

July 14, 2021 By Sean Whooley

TransMedics (NSDQ:TMDX) announced today that the Nasdaq market halted trading of the company’s common stock. Andover, Mass.-based TransMedics, which develops organ transplant transportation platforms, saw its common stock close down -5.3% at $31.69 yesterday. The company awaits the outcome of today’s meeting of the FDA’s Gastroenterology and Urology Devices Panel of the Medical Devices Advisory […]

Filed Under: Business/Financial News, Featured, Food & Drug Administration (FDA), Pre-Market Approval (PMA), Regulatory/Compliance, Transplants, Wall Street Beat Tagged With: FDA, FDA advisory panels, NASDAQ, transmedics

TransMedics says FDA advisory committee will review its OCS Liver System in July

June 11, 2021 By Sean Whooley

TransMedics (NSDQ:TMDX) announced that the FDA confirmed that it will review its premarket approval application next month. Andover, Mass.–based TransMedics said the FDA scheduled a public advisory committee meeting to review the PMA application for the OCS Liver System, an organ transplant transportation platform, for July 14, 2021. In the committee meeting, the FDA’s Gastroenterology […]

Filed Under: Featured, Food & Drug Administration (FDA), Pre-Market Approval (PMA), Regulatory/Compliance, Transplants Tagged With: FDA, FDA advisory panels, transmedics

FDA panel advises against assurable effectiveness of Neovasc Reducer

October 28, 2020 By Sean Whooley

Neovasc (NSDQ:NVCN) announced that an FDA advisory panel voted against reasonable assurance of effectiveness for its Reducer system. The FDA’s Circulatory System Devices Advisory Panel voted 1 to 17 “against” on the issue of “a reasonable assurance of effectiveness,” according to a news release. “We would like to thank the FDA, the panel and members of […]

Filed Under: Blood Management, Cardiac Implants, Cardiovascular, Featured, Food & Drug Administration (FDA), Pre-Market Approval (PMA), Regulatory/Compliance, Structural Heart Tagged With: FDA, FDA advisory panels, neovasc

FDA plans advisory panel on metal implants, dental alloys

September 30, 2019 By Sean Whooley

The FDA is slated to hold an advisory panel meeting to discuss immunology concerns about metal implants and dental alloys. The Immunology Devices Panel meeting of the Medical Devices Advisory Committee is scheduled for Nov. 13-14 of this year to discuss the use of the materials and assess the adequacy of current approaches and standards […]

Filed Under: Dental, Food & Drug Administration (FDA), Implants, Regulatory/Compliance Tagged With: FDA, FDA advisory panels

FDA sets meeting on EO sterilization

September 3, 2019 By Sean Whooley

The FDA said today that it will hold an advisory meeting on November 6 and November 7, 2019, to discuss the role of ethylene oxide (EO) sterilization of medical devices in public health, as well as the risks of the sterilization process. The general hospital and personal use devices panel of the FDA’s medical devices […]

Filed Under: Food & Drug Administration (FDA), Sterilization / Calibration Tagged With: ethylene oxide, FDA, FDA advisory panels

FDA panel recommends stiffer regulation of some surgical staplers

June 3, 2019 By Nancy Crotti

An FDA panel has recommended that surgical staplers for internal use be reclassified to a more highly regulated status. The General and Plastic Surgery Devices Panel met last week following a March alert the agency issued about internal-use surgical staplers. The devices have seen an uptick in concern over the past few months, with the FDA […]

Filed Under: Featured, Food & Drug Administration (FDA), News Well, Surgical Tagged With: FDA, FDA advisory panels, Popular Posts

FDA to publicly share advisory committee CVs

February 8, 2017 By Heather Thompson

The FDA’s ongoing commitment to transparency reached a new level last week, when the agency announced it would disclose the CVs of advisory committee members. The form will not include confidential or redacted information, said FDA. Outside experts often weigh in on scientific and medical issues that pertain to new drugs and devices, and FDA has […]

Filed Under: Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: FDA advisory panels

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy